News &

Media Contact

Amy Merves
Manager of
Media Relations



Fox Chase Cancer Center Adds Jeffrey M. Farma to Surgical Oncology Team

PHILADELPHIA (August 11, 2009) – Jeffrey M. Farma, MD, FACS - Co-Director, Cutaneous Oncology Program; Attending Surgeon, Surgical Oncology; Director, Surgical Oncology Fellowship, has joined Fox Chase Cancer Center as an attending surgeon in the department of surgical oncology.  At Fox Chase, Farma treats patients with melanomas, sarcomas, and gastrointestinal cancers.  His research interests include outcomes studies in gastrointestinal and cutaneous malignancies and regional therapies in the treatment of cancer.

“One of the greatest benefits of a cancer center like Fox Chase is the close knit group of expert physicians from all specialties that are constantly interacting and providing the highest level of care using the most innovative strategies to treat all aspects of cancer,” says Farma.

Farma comes to Fox Chase from the Moffitt Cancer Center, where he completed his clinical surgical oncology fellowship.  Prior to his fellowship at Moffitt, Farma completed his residency in general surgery at the Temple University.  He also completed a surgical oncology fellowship at the National Cancer Insitute, where he learned about clinical trial design, experimental therapeutics, and the importance of bench-to-bedside research.

“During my fellowship at the National Cancer Institute in Bethesda, Maryland, I encountered patients with very complex problems,” added Farma.  “The greatest lesson I learned was there are always treatment options, utilizing all different types of techniques including radiation, chemotherapy and surgery.”

Farma earned his MD from Temple University School of Medicine and BA from Tufts University.  He is certified by the American Board of Surgery and is an active member of a number of medical organizations.

Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach.  For more information, call 1-888-FOX CHASE or (1-888-369-2427).

More 2009 News Releases »